跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VITRAKVI CAPSULES 25MG - PPB Drug Approval Details
Approvals
/
PPB
/
VITRAKVI CAPSULES 25MG
Approved
STANDARD
VITRAKVI CAPSULES 25MG
BAYER HEALTHCARE LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
5f6e4a52a5a0064e
Company
BAYER HEALTHCARE LIMITED
Type
Standard
Approval Details
Approval Id
5f6e4a52a5a0064e
Product Name
VITRAKVI CAPSULES 25MG
Drug Hk Name
VITRAKVI CAPSULES 25MG
Registration Code
HK-66492
Company Name
BAYER HEALTHCARE LIMITED
Company Detail Path
/organization/bayer-healthcare-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2019-12-17
Company Address
14/F, OXFORD HOUSE, TAIKOO PLACE, 979 KING’S ROAD, QUARRY BAY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
5f6e4a52a5a0064e
Type
Standard
Back to PPB Approvals